Approval · Notice of Compliance 20590 · 2018
CELSENTRI: Notice of Compliance 20590
Issued March 5, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20590
- Date
- March 5, 2018
- Company
- Viiv Healthcare UlcMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of new alternate manufacturing site for ds, change in ds manufacturing process, deletions of ds manufacturing site and change in specifications for ds testing and acceptance criteria
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CELSENTRI | Not yet assigned | — |